PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsStomach neoplasms
MeSH D013274 - stomach neoplasms
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D005770:Gastrointestinal neoplasms
28 Companies
6 Drugs
$
Success rate
D013272:Stomach diseases
2 Companies
3 Drugs
$
Success rate
D013274: 
Stomach neoplasms
70 Companies
15 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Accord HealthcareCapecitabine Capecitabine Accord  2012-04-20   
Docetaxel Docetaxel  2011-06-08   
Docetaxel Docetaxel Accord  2012-05-22   
Fluorouracil Fluorouracil  2007-04-26   
Mitomycin Mitomycin  1998-04-30   
Trastuzumab Zercepac  2020-07-27   
Cisplatin Cisplatin  2015-08-18   
Irinotecan Irinotecan  2008-11-21   
Methotrexate Methotrexate  2007-04-30   
Alembic PharmaceuticalsDocetaxel Docetaxel  2023-02-28   
Fluorouracil Fluorouracil  2023-03-03   
Methotrexate Methotrexate  2024-06-03   
AllerganDocetaxel Docetaxel  2013-04-12   
Irinotecan Irinotecan  2008-02-27   
American RegentFloxuridine Floxuridine  2017-11-22   
AmgenTrastuzumab Kanjinti  2018-05-16   
Amneal PharmaceuticalsDocetaxel Docetaxel  2018-01-19   
Methotrexate Methotrexate  2017-12-22   
ApotexDocetaxel Docetaxel  2012-01-11   
APP PharmaceuticalsFluorouracil Fluorouracil  1986-03-21   
Methotrexate Methotrexate  1985-10-11   
Assertio TherapeuticsMethotrexate Otrexup 2026-01-24 2013-10-11 $9.498 M Q4/23-Q3/24 
Astex PharmaceuticalsMitomycin Mitozytrex  2002-11-14   
1
2
3
4
5
6
7
>
Clinical Trials
Historical Success Rate
Phase 1
74%
103/139
Phase 2
30%
57/192
Phase 3
41%
42/103
Approved: 16Overall Success rate: 9%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Accord Healthcare
Cisplatin,
Trastuzumab
Allergan
Docetaxel,
Aglatimagene besadenovec,
Bevifimod,
Docetaxol
Amgen
Trastuzumab,
Melarsoprol,
Aglatimagene besadenovec,
Rilotumumab,
Bevifimod,
Doxecitine,
Globulin, immune,
Anthracycline,
Nerofe,
Aminoglycoside,
Doxorubin,
Mk3475,
Pharmorubicin,
Histone-arginine methyltransferase carm1,
Hydroxydaunomycin,
Surlorian,
Docetaxol,
Fluoropyrimidine,
Taxane
Amneal Pharmaceuticals
Methotrexate
Astex Pharmaceuticals
Mitomycin,
Rubitecan
Barr Pharmaceuticals
Methotrexate
Bausch Health Companies
Fluorouracil
Baxter
Ifosfamide
Bristol Myers Squibb
Methotrexate,
Mitomycin,
Rucaparib,
Fluorodopa f-18,
Rucaparib camsylate,
Bempegaldesleukin,
Gilvetmab,
Linrodostat,
Bevifimod,
Doxecitine,
Nepidermin,
Polyglycolic acid,
Fludeoxyglucose f-18,
Globulin, immune,
Tj033721,
Capeox,
Endocrine,
Mk3475,
Folinoral,
Fluoropyrimidine,
Taxane
1
2
3
4
5
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use